Total Artificial Heart Implantation Blood Pressure Management as Resolving Treatment for Massive Hemolysis following Total Artificial Heart Implantation

Ghodsizad, A.; Koerner, M.M.; El-Banayosy, A.; Zeriouh, M.; Ruhparwar, A.; Loebe, M.

Heart Surgery Forum 19(5): E229

2016


ISSN/ISBN: 1098-3511
PMID: 27801302
Document Number: 689665
The SynCardia Total Artificial Heart (TAH) has been used for patients with biventricular failure, who cannot be managed with implantation of a left ventricular (LV) assist device. Following TAH implantation, our patient developed severe hemolysis, which could only be managed successfully by aggressive blood pressure control [Ohashi 2003; Nakata 1998].

Document emailed within 1 workday
Secure & encrypted payments